• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Video

Approaches to a Generalized Pustular Psoriasis Diagnosis (GPP)

Author(s):

Raj Chovatiya, MD, PhD, MSCI

Raj Chovatiya, MD, PhD, provides an overview of the factors he uses to lead to a diagnosis of generalized pustular psoriasis (GPP).

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Newsletter

      Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

      Subscribe Now!
      Related Videos
      2 experts in this video
      Safety Considerations for IL-17 Inhibitors
      2 experts in this video
      Selecting and Dosing IL-17 Inhibitors in Psoriasis
      2 experts in this video
      IL-17 Inhibitor Treatment Impact on Quality of Life in Psoriasis and Psoriatic Arthritis
      2 experts in this video
      Clinical Attributes of IL-17 Inhibitors in Psoriasis
      2 experts in this video
      Mechanism of Action Differences Among IL-17 Inhibitors
      2 experts in this video
      The Role of IL-17 in Psoriasis Pathogenesis
      New Research Confirms Effective Therapy for Nail Psoriasis
      New Research Confirms Effective Therapy for Nail Psoriasis
      New Biomarker Test Revolutionizes Inflammatory Skin Disease Diagnosis
      New Biomarker Test Revolutionizes Inflammatory Skin Disease Diagnosis
      Jeff Stark, MD: Discussing Bimzelx’s Efficacy and Future in Treating Inflammatory Skin Diseases
      Jeff Stark, MD: Discussing Bimzelx’s Efficacy and Future in Treating Inflammatory Skin Diseases
      Addressing Disparities in Inflammatory Skin Diseases in Darker Skin Tones
      Addressing Disparities in Inflammatory Skin Diseases in Darker Skin Tones
      Related Content
      Reduced Cardiovascular Risk with Biologics in Psoriasis and PsA
      April 3rd 2025

      Reduced Cardiovascular Risk with Biologics in Psoriasis and PsA

      The Cutaneous Connection: An Inside Look of the Inclusive Atlas
      November 4th 2021

      The Cutaneous Connection: An Inside Look of the Inclusive Atlas

      Guselkumab Shows Strong Response in Long-Term Subtype Psoriasis Study
      April 2nd 2025

      Guselkumab Shows Strong Response in Long-Term Subtype Psoriasis Study

      The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics
      September 23rd 2021

      The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics

      Patient and Physician Perspectives Assess Long-Term Impact of Tildrakizumab for Psoriasis
      March 27th 2025

      Patient and Physician Perspectives Assess Long-Term Impact of Tildrakizumab for Psoriasis

      Biologics Targeting IL-12, IL-23, and IL-17 Reduce Serious Infections in Older Adults with Psoriatic Disease
      March 25th 2025

      Biologics Targeting IL-12, IL-23, and IL-17 Reduce Serious Infections in Older Adults with Psoriatic Disease

      © 2025 MJH Life Sciences

      All rights reserved.